Jan 17, 2020 - J&J's (JNJ) cancer drugs are expected to have contributed significantly to fourth-quarter 2019 earnings. Generic/biosimilar headwinds are expected to have hurt Pharma unit's sales.
Jan 17, 2020 - Lilly (LLY) offers to buy Dermira for $1.1 billion. AstraZeneca (AZN) and AbbVie (ABBV) provide pipeline updates.
Jan 15, 2020 - New treatments for breast cancer, multiple sclerosis, and others make the drugmaker's stock a more compelling buy in 2020.
Jan 14, 2020 - The results should help the upstart drug to compete with Cosentyx.
Jan 13, 2020 - Cholesterol-lowering inclisiran could be available in the country as early as 2021.
Jan 13, 2020 - Alnylam (ALNY) announces preliminary results for the fourth quarter and 2019 and provides other updates.
Jan 10, 2020 - The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
Jan 09, 2020 - Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb
Jan 02, 2020 - The Gemini Solar Project in Nevada, which is expected to be the largest solar PV project in the U.S., moves closer to government approval after the Bureau of Land Management released a favorable final
Dec 31, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.